Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 291-297

  Rossi, Fabio ^a   Bertone, Cora ^a   Petricca, Silvia ^a   Santiemma, Vittorio ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Angiotensin II; Aorta; cAMP; Endothelium; Ghrelin; Migration

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ANGIOTENSIN II; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GHRELIN; KT 5720;

AORTA; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENINE; ADENYLATE CYCLASE; ANGIOTENSIN II; AORTA; CARBAZOLES; CELL MOVEMENT; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; HUMANS; INDOLES; OLIGOPEPTIDES; PEPTIDE HORMONES; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLES;

EID: 34248171685     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.07.021     Document Type: Article

References (40)

1. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 402 (1999) 656-660
2. Koijama M., and Kangawa K. Ghrelin: structure and function. Physiol Rev 85 (2005) 495-522
3. Papotti M., Ghe C., Cassoni P., et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 85 (2000) 3803-3807
4. Bodart V., Bouchard J.F., McNicoll N., et al. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ Res 85 (1999) 796-808
5. Enomoto M., Nagaya N., Uematsu M., et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci 105 (2003) 431-435
6. Nagaya N., Kojima M., Uematsu M., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regulatory 280 (2001) R1483-R1487
7. Nagaya N., Miyatake K., Uematsu M., et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 86 (2001) 5854-5859
8. Ghigo E., Arvat E., Broglio F., et al. Endocrine and nonendocrine activities of growth hormone secretagogues in humans. Horm Res 51 (1999) 9-15
9. Okumura H., Nagaya N., Enomoto M., et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 39 (2002) 779-783
10. Poykko S.M., Kellokoski E., Horkko S., et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
11. Li WG, Gavrila D, Liu X, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-{kappa}B activation in human endothelial cells. Circulation 2004;109:2221-2226.
12. Santiemma V., Beligotti F., Magnanti M., et al. Endothelin-1 stimulates deoxyribonucleic acid synthesis and contraction in testicular peritubular myoid cells. Biol Reprod 54 (1996) 583-590
13. Rossi F., Ferraresi A., Romagni P., Silvestroni L., and Santiemma V. Angiotensin II stimulates contraction and growth of testicular peritubular myoid cells in vitro. Endocrinology 143 (2002) 3096-3104
14. Albini A., D'Agostini F., Giunciuglio D., et al. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer 61 (1995) 121-129
15. Rossi F., Zappa C., Ferraresi A., and Santiemma V. Adrenomedullin inhibits angiotensin II-induced contraction in human aortic smooth muscle cells. Regul Pept 133 (2006) 155-159
16. Baldanzi G., Filigheddu N., Cutrupi S., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 23 (2002) 1029-1037
17. Malagon M.M., Luque R.M., Ruiz-Guerrero E., et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 144 (2003) 5372-5380
18. Wiley K.E., and Davenport A.P. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 136 (2002) 1146-1152
19. Katugampola S.D., Pallikaros Z., and Davenport A.P. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 134 (2001) 143-149
20. Goetze S., Bungenstock A., Czupalla C., et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension 40 (2002) 748-754
21. Kahn J., Mehraban F., Ingle G., et al. Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol 156 (2000) 1887-1900
22. Favot L., Keravis T., Holl V., Le Bec A., and Lugnier C. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thromb Haemost 90 (2003) 334-343
23. Newby A.C., and Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J Pathol 190 (2000) 300-309
24. Morales-Ruiz M., Fulton D., Sowa G., et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 86 (2000) 892-896
25. Netherton S.J., and Maurice D.H. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol Pharmacol 67 (2005) 263-272
26. Iwasaki T., Chen J.D., Kim J.P., Wynn K.C., and Woodley D.T. Dibutyryl cyclic AMP modulates keratinocyte migration without alteration of integrin expression. J Invest Dermatol 102 (1994) 891-897
27. Edin M.L., Howe A.K., and Juliano R.L. Inhibition of PKA blocks fibroblast migration in response to growth factors. Exp Cell Res 270 (2001) 214-222
28. Ydrenius L., Molony L., Ng-Sikorski J., and Andersson T. Dual action of cAMP-dependent protein kinase on granulocyte movement. Biochem Biophys Res Commun 235 (1997) 445-450
29. Howe A.K. Regulation of actin-based cell migration by cAMP/PKA. Biochim Biophys Acta 1692 (2004) 159-174
30. Kawasaki H., Springett G.M., Mochizuki N., et al. A family of cAMPbinding proteins that directly activate Rap1. Science 282 (1998) 2275-2279
31. de Rooij J., Zwartkruis F.J., Verheijen M.H., et al. Epac is a Rap1 guaninenucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
32. Bos J.L. EPAC: a new cAMP targhet and new avenues in cAMP research. Nat Rev Mol Cell Biol 4 (2003) 733-738
33. Oh J., Seo D.W., Diaz T., et al. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res 64 (2004) 9062-9069
34. Fujita H., Fukuhara S., Sakurai A., et al. Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes. Biol Chem 280 (2005) 5022-5031
35. Utsunomiya H., Nakamura M., Kakudo K., Inagami T., and Tamura M. Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice. Regul Pept 126 (2005) 155-161
36. Pueyo M.E., N'Diaye N., and Michel J.B. Angiotensin II-elicited signal transduction via AT1 receptors in endothelial cells. Br J Pharmacol 118 (1996) 79-84
37. Cai M., Zhang H., and Hui R. Single chain Fv antibody against angiopoietin-2 inhibits VEGF-induced endothelial cell proliferation and migration in vitro. Biochem Biophys Res Commun 309 (2003) 946-951
38. Benndorf R., Boger R.H., Ergun S., Steenpass A., and Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 93 (2003) 438-447
39. Desideri G., Bravi M.C., Tucci M., et al. Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability. Arterioscler Thromb Vasc Biol 23 (2003) 1218-1223
40. Montiel M., de la Blanca E.P., and Jimenez E. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells. Biochem Biophys Res Commun 327 (2005) 971-978